Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery

Annals of Thoracic Surgery

Volumn 79, Issue 2, 2005, Pages 728-740

  DiDomenico, Robert J ^a   Massad, Malek G ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLYCERYL TRINITRATE; IBUPROFEN; IRBESARTAN; KETOROLAC; MAGNESIUM SULFATE; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; TIMOLOL; VERAPAMIL;

BRADYCARDIA; CARDIOVASCULAR RISK; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; LIVER TOXICITY; LUNG FIBROSIS; MORBIDITY; OPEN HEART SURGERY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; THYROID DISEASE; TIME SERIES ANALYSIS;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANGIOTENSIN II; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CARDIAC SURGICAL PROCEDURES; DIGOXIN; HUMANS; POSTOPERATIVE CARE; RISK FACTORS; SOTALOL; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 13244295505     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.03.037     Document Type: Review

References (70)

1. Maisel W.H., Rawn J.D., Stevenson W.G. Atrial fibrillation after cardiac surgery. Ann Intern Med. 135:2001;1061-1073
2. Creswell L.L., Schuessler R.B., Rosenbloom M., Cox J.L. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 56:1993;539-549
3. Mathew J.P., Parks R., Savino J.S., Friedman A.S., Koch C., Mangano D.T. Atrial fibrillation following coronary artery bypass graft surgery predictors, outcomes, and resource utilization. Multicenter Study of Perioperative Ischemia Research Group. JAMA. 276:1996;300-306
4. Tamis J.E., Steinberg J.S. Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery. Clin Cardiol. 23:2000;155-159
5. Fuster V., Ryden L.E., Asinger R.W., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 38:2001;1231-1266
6. Jayam V.K.S., Flaker G.C., Jones J.W. Atrial fibrillation after coronary bypass etiology and pharmacologic prevention. Cardiovasc Surg. 10:2002;351-358
7. Chung M.K. Cardiac surgery postoperative arrhythmias. Crit Care Med. 28:(10 Suppl):2000;N136-144
8. Weber U.K., Osswald S., Huber M., et al. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J. 19:1998;794-800
9. Johnson L.W., Dickstein R.A., Fruehan C.T., et al. Prophylactic digitalization for coronary artery bypass surgery. Circulation. 53:1976;819-822
10. Tyras D.H., Stothert J.C. Jr, Kaiser G.C., Barner H.B., Codd J.E., Willman V.L. Supraventricular tachyarrhythmias after myocardial revascularization a randomized trial of prophylactic digitalization. J Thorac Cardiovasc Surg. 77:1979;310-314
11. Roffman J.A., Fieldman A. Digoxin and propranolol in the prophylaxis of supraventricular tachydysrhythmias after coronary artery bypass surgery. Ann Thorac Surg. 31:1981;496-501
12. Mills S.A., Poole G.V. Jr, Breyer R.H., et al. Digoxin and propranolol in the prophylaxis of dysrhythmias after coronary artery bypass grafting. Circulation. 68:1983;II222-225
13. Kowey P.R., Dalessandro D.A., Herbertson R., et al. Effectiveness of digitalis with or without acebutolol in preventing atrial arrhythmias after coronary artery surgery. Am J Cardiol. 79:1997;1114-1117
14. Yazicioglu L., Eryilmaz S., Sirlak M., et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. Eur J Cardiothorac Surg. 22:2002;397-401
15. Stephenson L.W., MacVaugh H. III, Tomasello D.N., Josephson M.E. Propranolol for prevention of postoperative cardiac arrhythmias a randomized study. Ann Thorac Surg. 29:1980;113-116
16. Mohr R., Smolinsky A., Goor D.A. Prevention of supraventricular tachyarrhythmias with low-dose propranolol after coronary bypass. J Thorac Cardiovasc Surg. 81:1981;840-845
17. Ivey M.F., Ivey T.D., Bailey W.W., Williams D.B., Hessel E.A. II, Miller D.W. Jr. Influence of propranolol on supraventricular tachycardia early after coronary revascularization. A randomized trial. J Thorac Cardiovasc Surg. 85:1983;214-218
18. White H.D., Elliott C.B., Antman E.M., et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation. 70:1984;479-484
19. Matangi M.F., Neutze J.M., Graham K.J., Hill D.G., Kerr A.R., Barratt-Boyes B.G. Arrhythmia prophylaxis after aorto-coronary bypass. The effect of minidose propranolol. J Thorac Cardiovasc Surg. 89:1985;439-443
20. Janssen J., Loomans L., Harink J., et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting a randomized open trial. Angiology. 37:1986;601-609
21. Daudon P., Corcos T., Gandjbakhch I., Levasseur J.P., Cabrol A., Cabrol C. Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. Am J Cardiol. 58:1986;933-936
22. Shafei H., Nashef S.A., Turner M.A., Bain W.H. Does low-dose propranolol reduce the incidence of supraventricular tachyarrhythmias following myocardial revascularization? A clinical study. Thorac Cardiovasc Surg. 36:1988;202-205
23. Lamb R.K., Prabhakar G., Thorpe J.A., Smith S., Norton R., Dyde J.A. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. Eur Heart J. 9:1988;32-36
24. Ali I.M., Sanalla A.A., Clark V. Beta-blocker effects on postoperative atrial fibrillation. Eur J Cardiothorac Surg. 11:1997;1154-1157
25. Connolly S.J., Cybulsky I., Lamy A., et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery. The β-Blocker Length of Stay (BLOS) study. Am Heart J. 145:2003;226-232
26. Merritt J.C., Niebauer M., Tarakji K., Hammer D., Mills R.M. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol. 92:2003;735-736
27. Mangano D.T., Layug E.L., Wallace A., Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 335:1996;1713-1720
28. Ferguson T.B., Coombs L.P., Peterson E.D. Preoperative β-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 287:2002;2221-2227
29. Smith E.E.J., Shore D.F., Monro J.L., Ross J.K. Oral verapamil fails to prevent supraventricular tachycardia following coronary artery surgery. Int J Cardiol. 9:1985;37-44
30. Hannes W., Fasol R., Zajonc H., et al. Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting. Eur J Cardiothorac Surg. 7:1993;239-245
31. Seitelberger R., Hannes W., Gleichauf M., Keilich M., Christoph M., Fasol R. Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting. J Thorac Cardiovasc Surg. 107:1994;811-821
32. Fanning W.J., Thomas C.S. Jr, Roach A., Tomichek R., Alford W.C., Stoney W.S. Jr. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg. 52:1991;529-533
33. 4 replacement. J Card Surg. 11:1996;421-427
34. Parikka H., Toivonen L., Pellinen T., Verkkala K., Jarvinen A., Nieminen M.S. The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation. Eur Heart J. 14:1993;251-258
35. Kaplan M., Kut M.S., Icer U.A., Demirtas M.M. Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 125:2003;344-352
36. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 324:1991;781-788
37. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 327:1992;227-233
38. McCary R.J., Jahnke E.J., Walker W.J. Ineffectiveness of quinidine in preventing atrial fibrillation following mitral valvotomy. Circulation. 34:1966;792-794
39. Merrick A.F., Odom N.J., Keenan D.J., Grotte G.J. Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias a prospective trial. Eur J Cardiothorac Surg. 9:1995;146-149
40. Laub G.W., Janeira L., Muralidharan S., et al. Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting a prospective, double-blind, randomized, placebo-controlled pilot study. Crit Care Med. 21:1993;1474-1478
41. Gold M.R., O'Gara P.T., Buckley M.J., DeSanctis R.W. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am J Cardiol. 78:1996;975-979
42. Suttorp M.J., Kinigma J.H., Tjon Joe Gin R.M., et al. Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg. 100:1990;921-926
43. Suttorp M.J., Kingma J.H., Peels H.O., et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol. 68:1991;1163-1169
44. Nystrom U., Edvardsson N., Berggren H., Pizzarelli G.P., Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg. 41:1993;34-37
45. Pfisterer M.E., Kloeter-Weber U.C.D., Huber M., et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol a prospective, double-blind, randomized, placebo-controlled study. Ann Thorac Surg. 64:1997;1113-1119
46. Parikka H., Toivonen L., Heikkilä L., Virtanen K., Järvinen A. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol. 31:1998;67-73
47. Gomes J.A., Ip J., Santoni-Rugiu F., et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 34:1999;334-339
48. Matsuura K., Takahara Y., Sudo Y., Ishida K. Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Jpn J Thorac Cardiovasc Surg. 49:2001;614-617
49. Forlani S., De Paulis R., de Notaris S., et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg. 74:2002;720-726
50. Betapace A.F. (Sotalol HCl) prescribing information. 2001;Berlex Laboratories, Wayne, NJ
51. Daoud E.G., Strickberger S.A., Man K.C., et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med. 337:1997;1785-1791
52. Redle J.D., Khurana S., Marzan R., et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J. 138:1999;144-150
53. Katariya K., DeMarchena E., Bolooki H. Oral amiodarone reduces incidence of postoperative atrial fibrillation. Ann Thorac Surg. 68:1999;1599-1604
54. Giri S., White C.M., Dunn A.B., et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST) a randomized placebo-controlled trial. Lancet. 357:2001;830-836
55. Maras D., Boskovic S.D., Popovic Z., et al. Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. Am Heart J. 141:2001;E8
56. White C.M., Giri S., Tsikouris J.P., et al. A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg. 74:2002;69-74
57. Yazigi A., Rahbani P., Zeid H.A., Madi-Jebara S., Haddad F., Hayek G. Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. J Cardiothorac Vasc Anesth. 16:2002;603-606
58. Mitchell LB. Prophylactic Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valvular Repair, or Replacement (PAPABEAR): preliminary results. American Heart Association Scientific Sessions; November 12, 2003; Orlando, FL (www.medscape.com/viewarticle/464674)
59. Butler J., Harriss D.R., Sinclair M., Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery a randomized, double blind, placebo controlled trial. Br Heart J. 70:1993;56-60
60. Guarnieri T., Nolan S., Gottlieb S.O., Dudek A., Lowry D.R. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery the Amiodarone Reduction in Coronary Heart (ARCH) Trial. J Am Coll Cardiol. 34:1999;343-347
61. Lee S.H., Chang C.M., Lu M.J., et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg. 70:2000;157-161
62. Dorge H., Schoendube F.A., Schoberer M., Stellbrink C., Voss M., Messmer B.J. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Surg. 69:2000;1358-1362
63. Tokmakoglu H., Kandemir O., Gunaydin S., Catav Z., Yorgancioglu C., Zorlutuna Y. Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation. Eur J Cardiothorac Surg. 21:2002;401-405
64. Yagdi T., Nalbantgil S., Ayik F., et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 125:2003;1420-1425
65. White C.M., Caron M.F., Kalus J.S., et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation. 108:(Suppl 2):2003;II200-206
66. Wurdeman R.L., Mooss A.N., Mohiuddin S.M., Lenz T.L. Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery a meta-analysis. Chest. 121:2002;1203-1210
67. Crystal E., Connolly S.J., Sleik K., Ginger T.J., Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery a meta-analysis. Circulation. 106:2002;75-80
68. Vermes E., Tardif J.C., Bourassa M.G., et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation. 107:2003;2926-2931
69. Madrid A.H., Bueno M.G., Rebollo J.M.G., et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation. 106:2002;331-336
70. Cheruku K.K., Ghani A., Ahmad F., et al. Efficacy of nonsteroidal antiinflammatory medications for prevention of atrial fibrillation following coronary artery bypass surgery. J Am Coll Cardiol. 39:2002;104A. abstract